Healthcare utilization
• Two hundred and sixty participants (26%) reported having a hospital visit (A&E visit or inpatient admission in previous 12 months. • One visit reported by 12.5%, two visits by 7.4%, three visits by 2.3%, four or more by 3.8%.
• At least one GP visit reported by 96.2% (median 4, IQR 2-6 visits)
Poisson regression
• Regardless of screening tool used, PIM and PPO exposure was associated with hospital visits.
• Except for START PPOs, PIM and PPO exposure was also associated with GP visits.
• The multivariable analysis for STOPP PIMs is displayed below (Table 2 ) and shows number of STOPP PIMs is independently associated with rate of hospital visits and GP visits, after adjusting for confounders. This study aims to determine the prevalence of PIMs and PPOs in a cohort of older people and their association with healthcare utilization.
Methods

Study design
• This was a retrospective cohort study of 2,051 community-dwelling participants in Wave 1 of The Irish Longitudinal Study on Ageing (TILDA) aged ≥65 years with linked medication dispensing history from a national pharmacy claims database.
• TILDA is a representative cohort of over 8,000 people resident in Ireland aged ≥50 years charting their health, social and economic circumstances.
• Medication data, classified by WHO Anatomical Therapeutic Chemical codes, was obtained from the Health Services Executive Primary Care Reimbursement Services (HSE-PCRS) pharmacy claims database, which details monthly medications dispensed to persons eligible for the General Medical Services (GMS) scheme in Ireland.
Exposure
Exposure to PIMs and PPOs was determined in the 12 months preceding each participant's TILDA interview using the Screening Tool for Older Persons' Prescriptions (STOPP 3 ), Beers criteria 4 , Assessing Care Of Vulnerable Elders (ACOVE) indicators 5 and the Screening Tool to Alert doctors to Right Treatment (START 3 ). Some indicators could not be applied due to lack of participant clinical information - Figure 1 shows the proportion of included criteria from each screening tool.
Figure 1. Percentage of included criteria from PIM and PPO screening tools
Outcome
As part of the TILDA interview, participants were asked about their healthcare utilization for a range of primary care and secondary care services in the previous 12 months. The outcome measures used for this study were self-reported number of hospital visits (emergency department of inpatient admissions) and number of general practitioner (GP) visits.
Data analysis
Poisson regression was used to determine the association between exposure to PIMs and exposure to PPOs and the rate of hospital and GP visits, adjusting for age, sex, education level, number of regular medications and chronic conditions and health insurance status. Separate models were fitted for each PIM and PPO screening tool and each of the two outcomes. Number of medications and chronic conditions were reported by participants during their TILDA interview. Analysis was performed using STATA version 12. • The percentage of participants with a PIM during the study period was 19.8-52.7% depending on screening tool used while PPO prevalence varied from 43.6-44.8% (Table 1 ).
Results
Overall prevalence
• 
